Symbols / CALA $0.00 +0.00% Calithera Biosciences, Inc.

Financial Services • Shell Companies • United States • PNK
CALA Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Financial Services
Industry Shell Companies
CEO
Exch · Country PNK · United States
Market Cap 974.00
Enterprise Value -1.44M
Income -21.29M
Sales
FCF (ttm) -28.17M
Book/sh -0.40
Cash/sh 5.22
Employees 8
Insider 10d
IPO Oct 02, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -0.00
PEG
P/S
P/B -0.00
P/C
EV/EBITDA 0.03
EV/Sales
Quick Ratio 3.44
Current Ratio 3.60
Debt/Eq 8.17
LT Debt/Eq
EPS (ttm) -2.65
EPS next Y -1.35
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2022-11-14
Earnings (prior) 2022-11-14
ROA -56.29%
ROE -114.14%
ROIC
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 4.87M
Shs Float 4.83M
Insider Own 0.00%
Instit Own 0.00%
Short Float 8.92%
Short Ratio 0.78
Short Interest 417.28K
52W High 0.00
vs 52W High -90.00%
52W Low 0.00
vs 52W Low 100.00%
Beta -1.07
Impl. Vol.
Rel Volume 0.83
Avg Volume 381.00
Volume 315.00
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $0.00
Price $0.00
Change 0.00%

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
High
Mean

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2022-11-15 down Ladenburg Thalmann Buy → Neutral
2022-11-15 down SVB Leerink Outperform → Market Perform $2
2022-08-29 up HC Wainwright & Co. Neutral → Buy $8
2022-08-16 main SVB Leerink — → Outperform $18
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2022-12-31 2021-12-31
Total Revenue
0.00
-100.00%
9.75
Operating Revenue
0.00
-100.00%
9.75
Operating Expense
42.07
-43.38%
74.31
Research And Development
28.53
-46.62%
53.45
Selling General And Administration
13.54
-35.06%
20.85
General And Administrative Expense
13.54
-35.06%
20.85
Other Gand A
13.54
-35.06%
20.85
Total Expenses
42.07
-43.38%
74.31
Operating Income
-42.07
+34.83%
-64.56
Total Operating Income As Reported
-42.07
+63.55%
-115.43
EBITDA
-41.82
+34.94%
-64.28
Normalized EBITDA
-43.77
-226.54%
-13.40
Reconciled Depreciation
0.26
-8.93%
0.28
EBIT
-42.07
+34.83%
-64.56
Total Unusual Items
1.95
+103.83%
-50.88
Total Unusual Items Excluding Goodwill
1.95
+103.83%
-50.88
Special Income Charges
0.00
+100.00%
-50.88
Other Special Charges
50.88
Net Income
-39.65
+65.55%
-115.09
Pretax Income
-39.65
+65.55%
-115.09
Net Non Operating Interest Income Expense
0.48
+38.26%
0.34
Net Interest Income
0.48
+38.26%
0.34
Interest Income Non Operating
0.48
+38.26%
0.34
Interest Income
0.48
+38.26%
0.34
Other Income Expense
1.95
+103.83%
-50.88
Gain On Sale Of Security
1.95
Tax Rate For Calcs
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
Net Income Including Noncontrolling Interests
-39.65
+65.55%
-115.09
Net Income From Continuing Operation Net Minority Interest
-39.65
+65.55%
-115.09
Net Income From Continuing And Discontinued Operation
-39.65
+65.55%
-115.09
Net Income Continuous Operations
-39.65
+65.55%
-115.09
Normalized Income
-41.60
+35.22%
-64.21
Net Income Common Stockholders
-21.29
+81.50%
-115.09
Otherunder Preferred Stock Dividend
-18.36
0.00
Diluted EPS
-31.20
Basic EPS
-31.20
Basic Average Shares
3.69
Diluted Average Shares
3.69
Diluted NI Availto Com Stockholders
-39.65
+65.55%
-115.09
Average Dilution Earnings
-18.36
0.00
Line Item Trend 2022-12-31 2021-12-31
Total Assets
28.68
-55.72%
64.76
Current Assets
26.62
-56.68%
61.45
Cash Cash Equivalents And Short Term Investments
25.45
-57.25%
59.54
Cash And Cash Equivalents
25.45
-57.25%
59.54
Other Short Term Investments
0.00
Receivables
0.00
Accounts Receivable
0.00
Prepaid Assets
1.92
Other Current Assets
1.17
-38.75%
1.92
Total Non Current Assets
2.05
-37.89%
3.30
Net PPE
1.78
-41.27%
3.03
Gross PPE
5.32
-16.01%
6.33
Accumulated Depreciation
-3.53
-7.26%
-3.29
Properties
0.00
0.00
Machinery Furniture Equipment
0.72
-2.18%
0.73
Other Properties
3.36
-22.87%
4.36
Leases
1.23
+0.00%
1.23
Other Non Current Assets
0.27
+0.00%
0.27
Total Liabilities Net Minority Interest
8.28
-85.31%
56.37
Current Liabilities
7.39
-47.24%
14.01
Payables And Accrued Expenses
5.67
-54.98%
12.59
Payables
0.73
-79.95%
3.65
Accounts Payable
0.73
-79.95%
3.65
Current Accrued Expenses
4.93
-44.78%
8.94
Current Debt And Capital Lease Obligation
1.53
+11.35%
1.37
Current Capital Lease Obligation
1.53
+11.35%
1.37
Other Current Liabilities
0.19
+328.89%
0.04
Total Non Current Liabilities Net Minority Interest
0.89
-97.89%
42.37
Long Term Debt And Capital Lease Obligation
0.14
-91.84%
1.67
Long Term Capital Lease Obligation
0.14
-91.84%
1.67
Preferred Securities Outside Stock Equity
0.00
-100.00%
40.70
Stockholders Equity
20.39
+143.28%
8.38
Common Stock Equity
-1.95
-123.26%
8.38
Capital Stock
22.34
0.00
Common Stock
0.00
0.00
Preferred Stock
22.34
0.00
Share Issued
4.87
+26.21%
3.86
Ordinary Shares Number
4.87
+26.21%
3.86
Additional Paid In Capital
510.67
+2.19%
499.71
Retained Earnings
-512.62
-4.33%
-491.33
Gains Losses Not Affecting Retained Earnings
0.00
Total Equity Gross Minority Interest
20.39
+143.28%
8.38
Total Capitalization
20.39
+143.28%
8.38
Working Capital
19.23
-59.46%
47.45
Invested Capital
-1.95
-123.26%
8.38
Total Debt
1.67
-45.20%
3.04
Capital Lease Obligations
1.67
-45.20%
3.04
Net Tangible Assets
20.39
+143.28%
8.38
Tangible Book Value
-1.95
-123.26%
8.38
Derivative Product Liabilities
0.76
0.00
Preferred Stock Equity
22.34
Line Item Trend 2022-12-31 2021-12-31
Operating Cash Flow
-43.61
+34.23%
-66.30
Cash Flow From Continuing Operating Activities
-43.61
+34.23%
-66.30
Net Income From Continuing Operations
-39.65
+65.55%
-115.09
Depreciation Amortization Depletion
0.26
-8.93%
0.28
Depreciation
0.26
-8.93%
0.28
Depreciation And Amortization
0.26
-8.93%
0.28
Other Non Cash Items
1.13
-97.29%
41.65
Stock Based Compensation
4.03
-60.74%
10.26
Operating Gains Losses
-1.95
Gain Loss On Investment Securities
-1.95
Change In Working Capital
-7.43
-118.09%
-3.40
Change In Receivables
0.00
-100.00%
1.54
Change In Prepaid Assets
0.74
+672.92%
0.10
Change In Payables And Accrued Expense
-6.79
-75.69%
-3.87
Change In Accrued Expense
-3.88
+29.82%
-5.52
Change In Payable
-2.92
-276.21%
1.66
Change In Account Payable
-2.92
-276.21%
1.66
Change In Other Current Assets
0.00
0.00
Change In Other Current Liabilities
-1.37
-16.94%
-1.18
Investing Cash Flow
-0.13
-101.69%
7.85
Cash Flow From Continuing Investing Activities
-0.13
-101.69%
7.85
Net PPE Purchase And Sale
-0.13
+9.52%
-0.15
Purchase Of PPE
-0.13
+9.52%
-0.15
Capital Expenditure
-0.13
+9.52%
-0.15
Net Investment Purchase And Sale
0.00
-100.00%
8.00
Purchase Of Investment
0.00
0.00
Sale Of Investment
0.00
-100.00%
8.00
Financing Cash Flow
9.65
-9.50%
10.67
Cash Flow From Continuing Financing Activities
9.65
-9.50%
10.67
Net Common Stock Issuance
9.64
-9.61%
10.66
Proceeds From Stock Option Exercised
0.02
-90.96%
0.18
Net Other Financing Charges
-0.17
Changes In Cash
-34.09
+28.66%
-47.78
Beginning Cash Position
59.81
-44.41%
107.59
End Cash Position
25.72
-56.99%
59.81
Free Cash Flow
-43.74
+34.17%
-66.45
Amortization Of Securities
0.00
-100.00%
0.00
Common Stock Issuance
9.64
-9.61%
10.66
Issuance Of Capital Stock
9.64
-9.61%
10.66
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category